Figure 1.
Unique considerations for sites of metastasis in mRCC. IL-2, interleukin-2; IMDC, International mRCC Database Consortium; mRCC, metastatic renal cell carcinoma; OS, overall survival; VEGF-TKIs, VEGF-tyrosine kinase inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.